TCS, HDFCBANK, SBI Liquid Fund (G)

Ipca Laboratories Ltd.

Ipca Laboratories

NSE

₹ 0.00

0.00 (0.00)%

Healthcare

Mid-cap

With a market cap of ₹18.90L Cr.

Moderate Volatility

Stock is 1.13x as volatile as index

To access realtime data for Reliance Industries Ltd, and use advance features for trading Register or Login to Orca.

EX-Date	Purpose
28 05 2021	Audited Results
05 08 2021	Quarterly Results
13 11 2021	Interim Dividend & Stock Split & Quarterly Results
14 02 2022	Quarterly Results
24 05 2022	Audited Results & Amalgamation
10 08 2022	Quarterly Results
11 11 2022	Quarterly Results & Interim Dividend
14 02 2023	Quarterly Results
29 05 2023	Audited Results
10 08 2023	Quarterly Results
10 11 2023	Quarterly Results & Interim Dividend
14 02 2024	Quarterly Results
30 09 2024	Inter alia, to consider and approve:- (1) Integration and consolidation of the generics formulations business in the US market of M/s. Bayshore Pharmaceuticals LLC (wholly owned step-down subsidiary) into Unichem Pharmaceuticals (USA) Inc. (wholly owned subsidiary of Company?s subsidiary)
14 11 2024	Quarterly Results & Interim Dividend
13 02 2025	Quarterly Results

News

03-AUG-2023

Ipca Laboratories acquires 33.38% stake in Unichem Laboratories

This deal was executed through block deal mechanism of National Stock Exchange of India

10:30 AM

05-DEC-2024

Ipca Laboratories secures approval for voluntary closure of Mexico-based subsidiary

Voluntary closure of this wholly owned subsidiary will not have any impact on Company’s business or financials

12:21 PM

13-NOV-2023

Ipca Laboratories reports 6% fall in Q2 consolidated net profit

Total consolidated income of the company increased by 26.59% at Rs 2,072.51 crore for Q2FY24

03:12 PM

14-JUN-2023

USFDA conducts inspection at Ipca Laboratories’ APIs manufacturing facility at Ratlam

At the conclusion of the inspection, the USFDA issued a Form 483 with 11 observations

09:31 AM

20-DEC-2022

Ipca Laboratories acquires further 6.53% stake in Trophic Wellness

Cash Consideration of Rs 10.58 crore was paid for the additional acquisition of 6.53% shareholding of TWPL

09:21 AM

23-OCT-2023

Ipca Laboratories gets VAI classification for Madhya Pradesh facility

USFDA inspected the company’s said manufacturing facility from June 05, 2023 to June 13, 2023

11:40 AM

24-APR-2023

Ipca Laboratories inks pact to acquire 33.4% stake in Unichem Laboratories

The business and product range of Ipca and that of Unichem complements each others business and product range

04:58 PM

24-AUG-2023

Ipca Laboratories gets VAI classification for Piparia manufacturing facility

Based on this inspection, this facility is considered to be in a minimally acceptable state of compliance with regards to current good manufacturing practice

10:21 AM

24-JUN-2023

USFDA conducts inspection at Ipca Laboratories’ formulations manufacturing facility in Pithampur

At the conclusion of the inspection, USFDA has issued a Form 483 with 8 observations

10:51 AM

27-APR-2023

USFDA conducts inspection at Ipca Laboratories’ formulations manufacturing unit at Piparia

At the conclusion of the inspection, the USFDA issued a Form 483 with 3 observations

09:24 AM

27-MAR-2024

Ipca Laboratories enters into Technology Transfer Agreement with Omexa Formulary

Ipca will grant to Omexa a non-exclusive right to research, develop, manufacture and market a anti-cancer biosimilar for global market

03:14 PM

31-OCT-2023

Ipca Laboratories gets VAI classification for Indore facility

USFDA inspected the company’s said manufacturing facility from June 15, 2023 to June 23, 2023

11:52 AM